A Phase I/II Study of GX15-070MS in Untreated CLL
NCT00600964
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG:
GX15-070MS
DRUG:
GX15-070MS
Sponsor
Gemin X